A
The startup develops a brain cancer therapy that utilizes AI to model the cellular and molecular pathology of patient tumors, including their complex microenvironments. This technology enables precise predictions of drug responses, allowing clinicians to tailor treatments for individual brain cancer patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a brain cancer therapy that utilizes AI to model the cellular and molecular pathology of patient tumors, including their complex microenvironments. This technology enables precise predictions of drug responses, allowing clinicians to tailor treatments for individual brain cancer patients.